The medical aesthetics market is hot, and at the moment, much of that heat is coming from a tantalizing emerging market for the treatment of cellulite. Consumer demand is so great for cellulite treatments that a $3 billion cosmeceutical market has been created around lotions and massagers with minimal efficacy. To reach a potential blockbuster market--85% of women have cellulite--new device companies aim to demonstrate efficacy with the same discipline that they have brought to traditional therapeutic markets, hoping to create competitive and sustainable advantages.
by Mary Stuart
Caffeine scrubs, seaweed wraps, ceramic-coated neoprene shorts, and inflatable hip boots are only some of the whacky remedies that have been tried, to no avail, on cellulite, the cottage-cheese textured...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
The US’ 90-day suspension of higher “reciprocal tariffs” will expire on 9 July, raising fears that the 31% tariff rate on Swiss medtech and other goods exported to the US might make a comeback. While the tariff situation changes on an almost daily basis, medtechs should forearm for any eventually, say local business organizations.
Guardant Health introduces a new germline panel test to help guide cancer treatment, assess the risk of secondary cancers in patients and identify family members at risk of cancer.
A Texas court's decision against US FDA regulation of lab-developed tests (LDTs) has introduced new uncertainties for clinical labs. Industry stakeholders are now worried about potential future regulations while also managing existing compliance requirements. Recent conference discussions underscored the complexities of FDA oversight.
